Does VELAGLUCERASE ALFA Cause Neoplasm malignant? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Neoplasm malignant have been filed in association with VELAGLUCERASE ALFA (VPRIV). This represents 0.6% of all adverse event reports for VELAGLUCERASE ALFA.
10
Reports of Neoplasm malignant with VELAGLUCERASE ALFA
0.6%
of all VELAGLUCERASE ALFA reports
3
Deaths
5
Hospitalizations
How Dangerous Is Neoplasm malignant From VELAGLUCERASE ALFA?
Of the 10 reports, 3 (30.0%) resulted in death, 5 (50.0%) required hospitalization.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VELAGLUCERASE ALFA. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does VELAGLUCERASE ALFA Cause?
Inappropriate schedule of product administration (197)
Product dose omission issue (188)
Covid-19 (163)
Fatigue (136)
Death (108)
Fall (104)
Pyrexia (101)
Malaise (98)
Weight increased (89)
Headache (88)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which VELAGLUCERASE ALFA Alternatives Have Lower Neoplasm malignant Risk?
VELAGLUCERASE ALFA vs VELCADE
VELAGLUCERASE ALFA vs VELETRI
VELAGLUCERASE ALFA vs VELIPARIB
VELAGLUCERASE ALFA vs VEMURAFENIB
VELAGLUCERASE ALFA vs VENETOCLAX